
Experts discuss practical strategies for early recognition and coordinated care of tardive dyskinesia to enhance patient outcomes and quality of life.

Experts discuss practical strategies for early recognition and coordinated care of tardive dyskinesia to enhance patient outcomes and quality of life.

Health care professionals discuss the risks of tardive dyskinesia in patients on dopamine receptor antagonists and emphasize the importance of education and monitoring.

In this episode, the panel focuses on how enhancing patient and clinician education can improve early recognition of tardive dyskinesia.

In this episode, the panel explains how structured assessments such as the Abnormal Involuntary Movement Scale are essential tools for identifying tardive dyskinesia and distinguishing it from other drug-induced movement disorders.

In this episode, panelists identify early recognition of tardive dyskinesia as a significant unmet need and describe key opportunities to improve screening.

In this episode, the panel discusses how clinicians determine whether treatment for tardive dyskinesia is warranted once abnormal movements are identified.